000

DAEWON PHARM

No trades
See on Supercharts
Market capitalization
‪312.92 B‬KRW
‪23.92 B‬KRW
‪526.95 B‬KRW
‪11.41 M‬
Beta (1Y)
0.10

About DAEWON PHARM

Headquarters
Seoul
Employees (FY)
‪1.22 K‬
Founded
1958
ISIN
KR7003220001
FIGI
BBG000C194Q7
Daewon Pharmaceutical Co., Ltd. engages in the production and sale of pharmaceutical products. It offers multivitamins, antipyretics, analgesics and anti-inflammatory, gastrointestinal, endocrine, antimicrobial, psychoneurotic, respiratory, cardiovascular and neuromuscular drugs. The company was founded by Boo-Hyeon Baek on January 7, 1958 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 003220 is 15140 KRW — it has increased by 2.57% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DAEWON PHARM stocks are traded under the ticker 003220.
DAEWON PHARM is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
003220 stock is 5.19% volatile and has beta coefficient of 0.10. Check out the list of the most volatile stocks — is DAEWON PHARM there?
One year price forecast for DAEWON PHARM has a max estimate of 23000 KRW and a min estimate of 19000 KRW.
DAEWON PHARM revenue for the last quarter amounts to ‪129.00 B‬ KRW despite the estimated figure of ‪129.10 B‬ KRW. In the next quarter revenue is expected to reach ‪138.80 B‬ KRW.
Yes, you can track DAEWON PHARM financials in yearly and quarterly reports right on TradingView.
003220 stock has risen by 6.47% compared to the previous week, the month change is a 0.07% rise, over the last year DAEWON PHARM has showed a 1.07% increase.
003220 net income for the last quarter is ‪749.45 M‬ KRW, while the quarter before that showed ‪5.46 B‬ KRW of net income which accounts for −86.26% change. Track more DAEWON PHARM financial stats to get the full picture.
Today DAEWON PHARM has the market capitalization of ‪312.85 B‬, it has decreased by 3.49% over the last week.
Yes, 003220 dividends are paid annually. The last dividend per share was 300.00 KRW. As of today, Dividend Yield (TTM)% is 2.03%. Tracking DAEWON PHARM dividends might help you take more informed decisions.
DAEWON PHARM dividend yield was 1.92% in 2023, and payout ratio reached 26.32%. The year before the numbers were 1.87% and 23.18% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 003220 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAEWON PHARM stock right from TradingView charts — choose your broker and connect to your account.
003220 reached its all-time high on Jul 24, 2020 with the price of 29960 KRW, and its all-time low was 1210 KRW and was reached on Oct 28, 2003.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪1.22 K‬ employees. See our rating of the largest employees — is DAEWON PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DAEWON PHARM technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DAEWON PHARM stock shows the sell signal. See more of DAEWON PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DAEWON PHARM future price: according to them, 003220 price has a max estimate of 23000.00 KRW and a min estimate of 19000.00 KRW. Read a more detailed DAEWON PHARM forecast: see what analysts think of DAEWON PHARM and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAEWON PHARM EBITDA is ‪50.71 B‬ KRW, and current EBITDA margin is 9.45%. See more stats in DAEWON PHARM financial statements.